Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,863 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 46,863 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $2.87 | $37.31 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,767 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 08, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.39 | $44.07 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,754 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 07, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.14 | $40.82 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,741 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 06, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.34 | $43.42 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,728 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 05, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.92 | $50.96 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,715 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 04, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $4.01 | $52.13 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,702 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 01, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.44 | $44.72 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,689 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 31, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.50 | $45.50 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 22 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,676 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 30, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.55 | $46.15 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 21 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,663 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 29, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.33 | $43.29 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,650 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 28, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.47 | $45.11 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,637 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 25, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.37 | $53.92 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,624 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 24, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.55 | $56.80 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,608 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 23, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.54 | $56.64 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,592 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 22, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.47 | $55.52 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,576 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 21, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.45 | $55.20 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,560 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 18, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.59 | $57.44 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,544 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 17, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.82 | $61.12 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,528 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 16, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.79 | $60.64 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,512 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 15, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.45 | $55.20 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,496 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 14, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.46 | $55.36 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,480 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 11, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.21 | $51.36 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,464 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 10, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.20 | $51.20 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,448 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 09, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.05 | $48.80 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,432 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 08, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.06 | $48.96 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,416 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 07, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.23 | $51.68 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,400 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 03, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.31 | $52.96 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,384 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 02, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.52 | $56.32 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,368 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| July 01, 2025 Filed Aug 11, 2025 13:00 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $3.56 | $56.96 |
DisclosureSEC source: 0001628280-25-039404 · wk-form4_1754917226.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,352 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 30, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 16 | $2.74 | $43.84 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,336 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 27, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $2.60 | $20.80 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,320 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 26, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $2.71 | $21.68 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,312 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 25, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.27 | $26.16 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,304 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 24, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $3.91 | $31.28 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,296 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 23, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.61 | $36.88 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,288 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 20, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.29 | $42.32 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,280 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 18, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.52 | $44.16 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,272 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 17, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.61 | $44.88 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,264 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 16, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.32 | $42.56 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,256 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 13, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.81 | $46.48 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,248 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 12, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.67 | $45.36 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,240 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 11, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.57 | $44.56 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,232 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 10, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $6.00 | $48.00 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,224 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 09, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.94 | $47.52 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,216 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 06, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.57 | $44.56 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,208 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 05, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.46 | $43.68 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,200 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 04, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.75 | $46.00 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,192 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 03, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.61 | $44.88 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,184 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| June 02, 2025 Filed Jul 11, 2025 21:48 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $5.20 | $41.60 |
DisclosureSEC source: 0001628280-25-034816 · wk-form4_1752270525.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,176 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| May 30, 2025 Filed Jun 6, 2025 12:38 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 8 | $4.93 | $39.44 |
DisclosureSEC source: 0001628280-25-029854 · wk-form4_1749213516.xml · nonDerivative · entry 21 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,168 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.